SCI Ventures

SCI Ventures is a novel evergreen venture capital fund headquartered in London, United Kingdom, founded in 2023 and formally launched with capital in mid-2024. The fund's singular mission is to catalyse innovative cures and restorative treatments for spinal cord injury and paralysis. It was created as the first-ever collaboration between five leading spinal cord injury foundations across the US, UK, and European Union: the Christopher and Dana Reeve Foundation, Wings for Life, Spinal Research, Promobilia, and the Shepherd Center. SCI Ventures launched with approximately $27 million of initial commitments toward a $40 million target, and is advised by a network of world-class neuroscientists and clinicians. The fund was founded by Cohen — a tech entrepreneur who co-founded both Tractable and Lazada, both unicorns above $1 billion in value — after his brother was paralysed in an accident. The investment team is led by Cohen as Founder, supported by Investment Principal Roman Rothaermel and Senior Investment Associate Karen Chan. Every potential portfolio company is evaluated against three criteria: clinical impact on spinal cord injury patients, scientific maturity, and financial return potential. The fund deploys primarily into Series A and Series B rounds in healthcare, life sciences, and neurotechnology. Across 4 disclosed investments, named portfolio companies include Precision Neuroscience — a brain-computer interface company in which SCI Ventures announced a seven-figure investment and strategic partnership in November 2025, providing Precision with access to the firm's patient, physician, and regulatory network — and OrangeX, which raised a $20 million Series B in August 2025. SCI Ventures occupies a rare position as a fund that blends venture philanthropy with commercial investing: foundation anchors provide mission alignment and clinical network access, while commercial discipline ensures the portfolio is built for durable financial returns alongside patient impact.